Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear …

L Chouliaras, A Thomas, M Malpetti… - Journal of Neurology …, 2022 - jnnp.bmj.com
Objectives This longitudinal study compared emerging plasma biomarkers for
neurodegenerative disease between controls, patients with Alzheimer's disease (AD), Lewy …

An adaptive measure of visuospatial impairment in dementia with lewy bodies

JR Phillips, E Matar… - Movement Disorders …, 2022 - Wiley Online Library
ABSTRACT Background Dementia with Lewy bodies (DLB) is a common cause of dementia
with poor prognosis and high hospitalization rates. DLB is frequently misdiagnosed, with …

Utilizing machine learning techniques to predict the blood-brain barrier permeability of compounds detected using LCQTOF-MS in Malaysian Kelulut honey

R Edros, TW Feng, RH Dong - SAR and QSAR in Environmental …, 2023 - Taylor & Francis
Current in silico modelling techniques, such as molecular dynamics, typically focus on
compounds with the highest concentration from chromatographic analyses for bioactivity …